Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2011
PRAME-specific Allo-HLA-restricted T cells with potent antitumor reactivity useful for therapeutic T-cell receptor gene transferAvital L Amir, Dirk M van der Steen, Marleen M van Loenen, et al.European Journal of Cancer (Oxford, England : 1990)|July 17, 2025
The association between pretreatment emotional distress and response to tumor-infiltrating lymphocyte therapy in advanced melanomaMees D Egeler, Sebastian Klobuch, Willemijn S Tak, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2012
Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell linesPauline Meij, Inge Jedema, Maarten L Zandvliet, et al.Blood|June 20, 2013
HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusionSanja Stevanovic, Cornelis A M van Bergen, Simone A P van Luxemburg-Heijs, et al.The Journal of Clinical Investigation|January 15, 2019
Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I van der Lee, Rogier M Reijmers, Maria W Honders, et al.The Journal of Clinical Investigation|January 10, 2017
Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell responseCornelis A M van Bergen, Simone A P van Luxemburg-Heijs, Liesbeth C de Wreede, et al.Leukemia|October 19, 2019
Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I/II studyMarthe C J Roex, Peter van Balen, Lothar Germeroth, et al.Cytotherapy|May 17, 2020
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costingsRenske M T Ten Ham, Anke M Hövels, Jarno Hoekman, et al.The British Journal of Surgery|June 6, 2025
Surgical considerations for tumour-infiltrating lymphocyte therapy in melanoma: results from a randomized phase III trialLiselotte Tas, Marie B Weitemeyer, Maartje W Rohaan, et al.Nature Communications|January 14, 2025
Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsiesThomas Kuilman, Deborah S Schrikkema, Jules Gadiot, et al.Pageof 7